Apixio, Inc., the leading provider of clinical data integration, search
and analytics for healthcare organizations, is introducing this week at
the HIMSS 2012 conference, a technology framework called the Clinical
Knowledge Exchange (CKX). Apixio’s CKX combines efficient patient data
aggregation with knowledge of optimal actions derived from big data
analysis to enable healthcare systems and Accountable Care Organizations
to meet their quality, outcome, reimbursement and cost objectives.
Clinical Knowledge Exchange is a technical framework that automates
extraction and delivery of precise and actionable information to a
person (e.g. clinician, care manager, or coder) or application, such as
a quality reporting system, that is best equipped to turn that knowledge
into results. By prioritizing information required to help achieve an
objective, the CKX framework places less information technology burden
on a healthcare organization. This approach can, in many cases, mitigate
privacy and data ownership issues.
“Integral to CKX is its sophisticated mapping of millions of medical
concepts with one another based upon their strength of association, as
determined by processing very large medical corpora, standard medical
terminologies and millions of clinical documents,” says Darren Schulte,
Chief Medical Officer for Apixio.
Based on these medical associations, for example, CKX can anticipate
that information in a patient record about Plavix, an anti-clotting
medication, would be highly relevant to a clinician searching that
patient’s history of coronary heart disease in their EHR. CKX can then
proactively inform the clinician that Plavix was mentioned in a recent
progress note’s medication list but is absent from the patient’s
reconciled medication list - a potential quality of care gap. Similarly,
CKX can recognize that a sudden increase in a congestive heart failure
patient’s body weight, as recorded in a third-party patient portal, may
be indicative of an impending medical crisis. This prompts CKX to send
an action notification to the application used by the patient’s clinical
team, potentially preventing a hospital admission.
Using medical associations, CKX reveals clinical data hidden in
narrative text and scanned documents across the community, which has
been shown to represent more than 60% of a patient’s key clinical
history. As an example, CKX can intelligently extract diabetic foot
exams documented in narrative text, structure and intelligently codify
the information, and deliver it to quality reporting and decision
support tools, in essence providing information that far better
represents the patient experience.
CKX can analyze and identify trends in clinical and billing data and
adapt its models so that information can be used more efficiently in a
healthcare system to achieve specific financial objectives. For example,
Apixio has proven that capitated payments under the Medicare Advantage
Plan can be significantly increased by healthcare organizations using
CKX. The CKX framework identifies key knowledge about a patient’s
medical history that has not been documented for Medicare Advantage HCC
coding and routes it to a clinician or coder within their existing
workflow. This knowledge exchange allows actions to be taken that result
in more accurate risk characterization and higher capitated payments.
“High-value care can be realized once we turn patient data aggregated
from many different sources into clinical knowledge and can easily
deliver it to care providers and systems within a healthcare application
network,” says Shawn Dastmalchi, Chief Executive Officer for Apixio.
“With more provider- and consumer-facing applications connected into the
CKX, the more valuable and powerful this framework becomes.”
About Apixio Inc.
Privately held and based in San Mateo, California, Apixio Inc. is the
leading provider of integration, search and big data analytics solutions
for healthcare organizations. Apixio helps healthcare organizations
deliver high-value care by enabling them to better leverage data.

Source(s) : Apixio, Inc.